Does Stopping Amiodarone after Successfully Treating Atrial Fibrillation Occurring after Cardiac Surgery Increase the Risk of Recurrence?
DOI:
https://doi.org/10.1532/HSF98.20071216Abstract
Objectives: Atrial fibrillation (AF) following cardiac surgery is common and can complicate postoperative recovery. Amiodarone is a drug frequently used for cardioversion. Some clinicians advocate only in-hospital use of amiodarone until cardioversion, whereas others continue its use for several weeks following cardiac surgery. Inadvertent long-term administration of the drug could be harmful. This study assessed the risk of AF recurrence under 2 different regimens of amiodarone treatment.
Methods: From January 2005 to July 2007, we reviewed 296 patients who developed postoperative AF. Group A consisted of 198 patients who were discharged on amiodarone treatment, and group B consisted of 98 patients who were discharged without amiodarone treatment. The patients were followed for 8 weeks after cardiac surgery and were observed for the development of symptoms such as palpitations, transient ischemic attack (TIA), stroke, and recurrence of or readmission for AF. In addition, we evaluated a control group of 145 patients with similar characteristics and no postoperative AF for the incidence of stroke and AF and compared the results with their rates in the study groups.
Results: Patients discharged on amiodarone therapy were more likely to experience episodes of palpitations than those not on amiodarone (13% versus 10%); however, the rates of AF recurrence were almost the same for the 2 groups (8% and 9%, respectively). The 2 groups also showed no difference in the incidence of TIA and stroke (5% versus 4%). A low incidence of stroke and AF (1%-2%) was observed in patients with no perioperative AF.
Conclusions: Long-term treatment of patients with amiodarone should be reconsidered, because it may not be as effective as previously thought in preventing symptoms and AF recurrence. The surprising incidence of neurologic events requires further investigation.
References
Abreu JE, Reilly J, Salzano RP, Khachane VB, Jekel JF, Clyne CA. 1999. Comparison of frequencies of atrial fibrillation after coronary artery bypass grafting with and without the use of cardiopulmonary bypass. Am J Cardiol83:775-6, A9.nAlmassi GH, Schowalter T, Nicolosi AC, et al. 1997. Atrial fibrillation after cardiac surgery: a major morbid event? Ann Surg226:501-11.nBradley D, Creswell L, Hogue C, Epstein A, Prystowsky E, Daoud E. 2005. Pharmacologic prophylaxis. Chest128:39S-47S.nCrosby LH, Pifalo WB, Woll KR, Burkholder JA. 1990. Risk factors for atrial fibrillation after coronary artery bypass grafting. Am J Cardiol66:1520-2.nCrystal E, Kahn S. 2003. Long-term amiodarone therapy and the risk of complications after cardiac surgery: results from the Canadian Amiodarone Myocardial Infarction Arrhythmia Trial (CAMIAT). J Thorac Cardiovasc Surg125:633-7.nDiDomenico RJ, Massad MG. 2005. Pharmacologic strategies for prevention of atrial fibrillation after open heart surgery. Ann Thorac Surg79:728-40.nDimopoulou I, Marathias K, Daganou M, et al. 1997. Low-dose amiodarone-related complications after cardiac operations. J Thorac Cardiovasc Surg114:31-7.nGavaghan TP, Feneley MP, Campbell TJ, Morgan JJ. 1985. Atrial tachy-arrhythmias after cardiac surgery: results of disopyramide therapy. Aust N Z J Med15:27-32.nJayam VKS, Flaker GC, Jones JW. 2002. Atrial fibrillation after coronary bypass: etiology and pharmacologic prevention. Cardiovasc Surg10:351-8.nKim MH, Deeb GM, Morady F, et al. 2001. Effect of postoperative atrial fibrillation on length of stay after cardiac surgery (the Postoperative Atrial Fibrillation in Cardiac Surgery Study [PACS2]). Am J Cardiol87:881-5.nKwatra MM. 2006. Prevention of atrial fibrillation following cardiac surgery. JAMA295:2247-8, author reply 2248.nLiberman BA, Teasdale SJ. 1985. Anaesthesia and amiodarone. Can Anaesth Soc J 32:629-38.nMaisel W, Rawn J, Stevenson W. 2001. Atrial fibrillation after cardiac surgery. Ann Intern Med135:1061-73.nMartinez E, Bass E, Zimetbaum P. 2005. Pharmacologic control of rhythm. Chest128:48S-55S.nMason JW. 1987. Amiodarone. N Engl J Med316:455-66.nMathew JP, Parks R, Savino JS, Friedman AS, Koch C, Mangano DT. 1996. Atrial fibrillation following coronary artery bypass graft surgery: predictors, outcomes, and resource utilization. Multicenter Study of Perioperative Ischemia Research Group. JAMA276:300-6.nTerada Y, Mitsui T, Yamaguchi I. 1994. Conduction disturbances after open heart operation in a patient receiving amiodarone. Ann Thorac Surg58:1213-4.nVanderLugt JT, Mattioni T, Denker S, et al. 1999. Efficacy and safety of ibutilide fumarate for the conversion of atrial arrhythmias after cardiac surgery. Circulation100:369-75.nWeber UK, Osswald S, Huber M, et al. 1998. Selective versus non-selective antiarrhythmic approach for prevention of atrial fibrillation after coronary surgery: is there a need for preoperative risk stratification? A prospective placebo-controlled study using low-dose sotalol. Eur Heart J19:794-800.nCampbell TJ, Morgan JJ. 1980. Treatment of atrial arrhythmias after cardiac surgery with intravenous disopyramide. Aust N Z J Med10:644-9.nChung MK. 2000. Cardiac surgery: postoperative arrhythmias. Crit Care Med28(suppl):N136-44.nCochrane AD, Siddins M, Rosenfeldt FL, et al. 1994. A comparison of amiodarone and digoxin for treatment of supraventricular arrhythmias after cardiac surgery. Eur J Cardiothorac Surg8:194-8.nCreswell LL, Schuessler RB, Rosenbloom M, Cox JL. 1993. Hazards of postoperative atrial arrhythmias. Ann Thorac Surg56:539-49.n
